Literature DB >> 18437601

Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.

Hiroshi Terunuma1, Xuewen Deng, Zahidunnabi Dewan, Shigeyoshi Fujimoto, Naoki Yamamoto.   

Abstract

Natural killer (NK) cells recognize tumor cells and virus-infected cells and attack without being sensitized to antigens. The development of the antitumor/antivirus activities of NK cells is controlled by multiple mechanisms such as direct cytotoxic activity against target cells, antibody-dependent cell-mediated cytotoxicity, secretion of Th1-type cytokines, and interactions with dendritic cells. The development of these activities plays a significant role in both innate and adaptive immunities. Considering the recent progress made in elucidating the molecular and cellular biology of NK cells, we summarize the current situation and discuss future possibilities with regard to NK cell-based adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437601     DOI: 10.1080/08830180801911743

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  34 in total

1.  Cell-based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report.

Authors:  Ranganathan Chidambaram; Hiroshi Terunuma; Madasamy Balamurugan; Vidyasagar Devaprasad Dedeepiya; Premkumar Sumana; Rajappa Senthilkumar; Mathaiyan Rajmohan; Ramalingam Karthick; Senthilkumar Preethy; Samuel J K Abraham
Journal:  Mol Clin Oncol       Date:  2017-07-19

2.  Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.

Authors:  Timothy L Frankel; William Burns; John Riley; Richard A Morgan; Jeremy L Davis; Kenichi Hanada; Martha Quezado; Steven A Rosenberg; Richard E Royal
Journal:  Cancer Immunol Immunother       Date:  2010-08-24       Impact factor: 6.968

3.  Epirubicin pretreatment enhances NK cell-mediated cytotoxicity against breast cancer cells in vitro.

Authors:  Hui Feng; Ying Dong; Jing Wu; Yuan Qiao; Ge Zhu; Haofan Jin; Jiuwei Cui; Wei Li; Yong-Jun Liu; Jingtao Chen; Yanqiu Song
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.

Authors:  Liat Sorski; Rivka Melamed; Pini Matzner; Hagar Lavon; Lee Shaashua; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2016-05-25       Impact factor: 7.217

5.  Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.

Authors:  Masanori Kawano; Hideji Nishida; Yasunari Nakamoto; Hiroshi Tsumura; Hiroyuki Tsuchiya
Journal:  Clin Orthop Relat Res       Date:  2010-03-16       Impact factor: 4.176

6.  Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.

Authors:  Mahdi Mahmoudi; Faranak Fallahian; Soheila Sobhani; Shima Ghoroghi; Ahmadreza Jamshidi; Shiva Poursani; Masoumeh Dolati; Zahra Hosseinpour; Farhad Gharibdoost
Journal:  Clin Rheumatol       Date:  2017-01-24       Impact factor: 2.980

7.  Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.

Authors:  Xiuying Li; Yongsheng Wang; Yuwei Zhao; Hengxiu Yang; Aiping Tong; Chengjian Zhao; Huashan Shi; Yang Li; Zhenlin Wang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

8.  A comparative analysis of in vitro expansion of natural killer cells of a patient with autoimmune haemolytic anaemia and ovarian cancer with patients with other solid tumours.

Authors:  Vidyasagar Devaprasad Dedeepiya; Hiroshi Terunuma; Xuewen Deng; Subramani Baskar; Sadananda Rao Manjunath; Rajappa Senthilkumar; Palanisamy Murugan; Paramasivam Thamaraikannan; Thangavelu Srinivasan; Senthilkumar Preethy; Samuel J K Abraham
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

9.  Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.

Authors:  Baskar Subramani; Chithra Ramanathan Pullai; Kohila Krishnan; Sheela Devi Sugadan; Xuewen Deng; Terunuma Hiroshi; Kananathan Ratnavelu
Journal:  Biomed Rep       Date:  2014-03-26

10.  Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.

Authors:  Lyudmila G Burdelya; Craig M Brackett; Bojidar Kojouharov; Ilya I Gitlin; Katerina I Leonova; Anatoli S Gleiberman; Semra Aygun-Sunar; Jean Veith; Christopher Johnson; Gary J Haderski; Patricia Stanhope-Baker; Shyam Allamaneni; Joseph Skitzki; Ming Zeng; Elena Martsen; Alexander Medvedev; Dmitry Scheblyakov; Nataliya M Artemicheva; Denis Y Logunov; Alexander L Gintsburg; Boris S Naroditsky; Sergei S Makarov; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.